Samsara BioCapital, LLC - BIONTECH SE ownership

BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 297 filers reported holding BIONTECH SE in Q2 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of BIONTECH SE
ValueSharesWeighting
Q1 2022$688,000
-33.8%
4,0310.0%0.17%
-14.4%
Q4 2021$1,039,000
-33.9%
4,031
-30.0%
0.20%
-18.2%
Q3 2021$1,572,000
+22.0%
5,7580.0%0.25%
+55.3%
Q2 2021$1,289,000
+9.3%
5,758
-46.7%
0.16%
-26.7%
Q1 2021$1,179,000
+34.0%
10,7950.0%0.22%
+146.6%
Q4 2020$880,000
+0.1%
10,795
-15.0%
0.09%
-64.1%
Q3 2020$879,00012,7000.24%
Other shareholders
BIONTECH SE shareholders Q2 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 148,674$16,151,94319.26%
Quinn Opportunity Partners LLC 659,383$71,635,3699.22%
Systrade AG 50,000$5,432,0004.70%
Crocodile Capital Partners GmbH 29,586$3,214,2233.03%
ALTRINSIC GLOBAL ADVISORS LLC 700,421$76,093,7372.94%
Temasek Holdings (Private) Ltd 4,518,080$490,844,2112.92%
PARUS FINANCE (UK) Ltd 25,662$2,787,9201.74%
FLOSSBACH VON STORCH AG 3,513,215$381,675,6781.68%
AtonRa Partners 4,707$511,3681.07%
Baader Bank Aktiengesellschaft 135,093$14,617,4560.99%
View complete list of BIONTECH SE shareholders